Monogram Biosciences Inc (MGRM)

[forgreen]

MGRM is a full on buy now. Convergent factors make this stock a serious bull in the weeks ahead. Selling from Russell delisting is coming to an end this week. Shorts accomplished their goal in making that happen. They are covering while others accumulate. Huge institutional ownership makes this float far smaller than many realize. And Pfizer's approval of Maraviroc, hence a serious ramp up in MGRM's Trofile usage (and subsequent analyst upgrades pending), is imminent with unanimous fast track recommendation meaning approcal is perhaps days away, but likely no more than weeks. This is the perfect momentum entry. The upside is quite large. 2 analysts have set $3 and $3.25 targets, though in reality this could be a future $10 stock in the coming 18 months. MGRM is a strong buy now. I hold a half million shares and have the conviction I made the right move into this stock.